S Shafaghi؛ K Najafizadeh؛ K Sheikhy؛ Z Ansari Aval؛ B Farzanegan؛ Y Mafhoomi؛ Z Faghih Abdollahi؛ H Emami؛ E Mortaz؛ M Porabdollah؛ A Jahangiri Fard؛ M Nikobayan Safaei؛ A Slama؛ C Aigner؛ FS Hosseini-Baharanchi؛ A Abbasi Dezfuli (Shiraz, Abu Ali Sina member transplantation research center, 2016-10-19)
Background: Although lung transplantation is a well-accepted treatment for end-stage lung diseases patients, only 15%–20% of the brain-dead donors’ lungs are usable for transplantation. This results in high mortality of ...
